Cargando…
Selective vulnerability of inhibitory networks in multiple sclerosis
In multiple sclerosis (MS), a chronic demyelinating disease of the central nervous system, neurodegeneration is detected early in the disease course and is associated with the long-term disability of patients. Neurodegeneration is linked to both inflammation and demyelination, but its exact cause re...
Autores principales: | , , , , , , , |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Springer Berlin Heidelberg
2021
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7882577/ https://www.ncbi.nlm.nih.gov/pubmed/33449171 http://dx.doi.org/10.1007/s00401-020-02258-z |
_version_ | 1783651078317801472 |
---|---|
author | Zoupi, Lida Booker, Sam A. Eigel, Dimitri Werner, Carsten Kind, Peter C. Spires-Jones, Tara L. Newland, Ben Williams, Anna C. |
author_facet | Zoupi, Lida Booker, Sam A. Eigel, Dimitri Werner, Carsten Kind, Peter C. Spires-Jones, Tara L. Newland, Ben Williams, Anna C. |
author_sort | Zoupi, Lida |
collection | PubMed |
description | In multiple sclerosis (MS), a chronic demyelinating disease of the central nervous system, neurodegeneration is detected early in the disease course and is associated with the long-term disability of patients. Neurodegeneration is linked to both inflammation and demyelination, but its exact cause remains unknown. This gap in knowledge contributes to the current lack of treatments for the neurodegenerative phase of MS. Here we ask if neurodegeneration in MS affects specific neuronal components and if it is the result of demyelination. Neuropathological examination of secondary progressive MS motor cortices revealed a selective vulnerability of inhibitory interneurons in MS. The generation of a rodent model of focal subpial cortical demyelination reproduces this selective neurodegeneration providing a new preclinical model for the study of neuroprotective treatments. SUPPLEMENTARY INFORMATION: The online version contains supplementary material available at 10.1007/s00401-020-02258-z. |
format | Online Article Text |
id | pubmed-7882577 |
institution | National Center for Biotechnology Information |
language | English |
publishDate | 2021 |
publisher | Springer Berlin Heidelberg |
record_format | MEDLINE/PubMed |
spelling | pubmed-78825772021-02-25 Selective vulnerability of inhibitory networks in multiple sclerosis Zoupi, Lida Booker, Sam A. Eigel, Dimitri Werner, Carsten Kind, Peter C. Spires-Jones, Tara L. Newland, Ben Williams, Anna C. Acta Neuropathol Original Paper In multiple sclerosis (MS), a chronic demyelinating disease of the central nervous system, neurodegeneration is detected early in the disease course and is associated with the long-term disability of patients. Neurodegeneration is linked to both inflammation and demyelination, but its exact cause remains unknown. This gap in knowledge contributes to the current lack of treatments for the neurodegenerative phase of MS. Here we ask if neurodegeneration in MS affects specific neuronal components and if it is the result of demyelination. Neuropathological examination of secondary progressive MS motor cortices revealed a selective vulnerability of inhibitory interneurons in MS. The generation of a rodent model of focal subpial cortical demyelination reproduces this selective neurodegeneration providing a new preclinical model for the study of neuroprotective treatments. SUPPLEMENTARY INFORMATION: The online version contains supplementary material available at 10.1007/s00401-020-02258-z. Springer Berlin Heidelberg 2021-01-15 2021 /pmc/articles/PMC7882577/ /pubmed/33449171 http://dx.doi.org/10.1007/s00401-020-02258-z Text en © The Author(s) 2021 Open AccessThis article is licensed under a Creative Commons Attribution 4.0 International License, which permits use, sharing, adaptation, distribution and reproduction in any medium or format, as long as you give appropriate credit to the original author(s) and the source, provide a link to the Creative Commons licence, and indicate if changes were made. The images or other third party material in this article are included in the article's Creative Commons licence, unless indicated otherwise in a credit line to the material. If material is not included in the article's Creative Commons licence and your intended use is not permitted by statutory regulation or exceeds the permitted use, you will need to obtain permission directly from the copyright holder. To view a copy of this licence, visit http://creativecommons.org/licenses/by/4.0/. |
spellingShingle | Original Paper Zoupi, Lida Booker, Sam A. Eigel, Dimitri Werner, Carsten Kind, Peter C. Spires-Jones, Tara L. Newland, Ben Williams, Anna C. Selective vulnerability of inhibitory networks in multiple sclerosis |
title | Selective vulnerability of inhibitory networks in multiple sclerosis |
title_full | Selective vulnerability of inhibitory networks in multiple sclerosis |
title_fullStr | Selective vulnerability of inhibitory networks in multiple sclerosis |
title_full_unstemmed | Selective vulnerability of inhibitory networks in multiple sclerosis |
title_short | Selective vulnerability of inhibitory networks in multiple sclerosis |
title_sort | selective vulnerability of inhibitory networks in multiple sclerosis |
topic | Original Paper |
url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7882577/ https://www.ncbi.nlm.nih.gov/pubmed/33449171 http://dx.doi.org/10.1007/s00401-020-02258-z |
work_keys_str_mv | AT zoupilida selectivevulnerabilityofinhibitorynetworksinmultiplesclerosis AT bookersama selectivevulnerabilityofinhibitorynetworksinmultiplesclerosis AT eigeldimitri selectivevulnerabilityofinhibitorynetworksinmultiplesclerosis AT wernercarsten selectivevulnerabilityofinhibitorynetworksinmultiplesclerosis AT kindpeterc selectivevulnerabilityofinhibitorynetworksinmultiplesclerosis AT spiresjonestaral selectivevulnerabilityofinhibitorynetworksinmultiplesclerosis AT newlandben selectivevulnerabilityofinhibitorynetworksinmultiplesclerosis AT williamsannac selectivevulnerabilityofinhibitorynetworksinmultiplesclerosis |